NCT03205436View on ClinicalTrials.gov

Affinity Prospective Diabetic Foot Trial Crossover Group

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 15, 2019

Study Completion Date

August 15, 2019

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

Affinity human amniotic membrane

fresh hypothermically stored human amniotic membrane

Trial Locations (6)

15222

SerenaGroup Research Institute, Pittsburgh

16201

Armstrong County Memorial Hospital, Kittanning

16226

The Foot and Ankle Wellness Center, Ford City

17402

Martin Foot and Ankle, York

33016

GF Professional Research, Miami Lakes

33169

Barry University Clinical Research, North Miami Beach

Sponsors

Lead Sponsor

Organogenesis
All Listed Sponsors
collaborator

SerenaGroup, Inc.

NETWORK

lead

Organogenesis

INDUSTRY

NCT03205436 - Affinity Prospective Diabetic Foot Trial Crossover Group | Biotech Hunter | Biotech Hunter